Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,071.32
(
-0.53%
)
US TECH 100
25,769.38
(
-0.40%
)
Dow Jones
49,247.88
(
-0.40%
)
Brent Oil
94.33
(
4.03%
)
Bitcoin
75,799.86
(
-0.12%
)
News Focus
News Focus
Post# of 517467
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

scorman1

Send PM Follow Ignore
Followers 3
Posts 165
Boards Moderated 0
Alias Born 02/11/2023

scorman1

Re: kevindenver post# 437209

Thursday, 10/26/2023 5:33:39 PM

Thursday, October 26, 2023 5:33:39 PM

Post# of 517467

therefore $1249 is reasonable target should Blarcamesine be approved and traditional valuation metrics used.


presuming the world stands still, which it doesn't....against the submarginal SOC, yes....against the two competitors who are finishing large AD phase 3 trials in 2024.....big NO !
competition is not standing still..... tempus fugit
We need clean, unambiguous Rett first, then let us see how the market responds
Bullish
Bullish
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News